“…Furthermore, the recently published E-SIRIUS trial demonstrated even lower rates of restenosis than did the SIRIUS trial (5.1% vs 8.9%). 31 Recently, Suárez et al 32 presented the first series of patients with unprotected left main coronary artery lesions treated with drug-eluting stents. Forty-seven patients underwent stenting with a sirolimus-eluting stent.…”